Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-amino-3-(3-hydroxypropylthio)propionic Acid
2. Ss320 A
3. Ss320a
1. 13189-98-5
2. S-(3-hydroxypropyl)-l-cysteine
3. Cleanal
4. L-cysteine, S-(3-hydroxypropyl)-
5. Fudosteine [inn]
6. (-)-3-((3-hydroxypropyl)thio)-l-alanine
7. Ur9vpi71pt
8. (2r)-2-amino-3-[(3-hydroxypropyl)sulfanyl]propanoic Acid
9. Ncgc00164556-01
10. Dsstox_cid_26440
11. Dsstox_rid_81616
12. Dsstox_gsid_46440
13. (r)-2-amino-3-((3-hydroxypropyl)thio)propanoic Acid
14. Fudostein
15. Cleanal (tn)
16. Cas-13189-98-5
17. Ss320a
18. Unii-ur9vpi71pt
19. Spelear
20. (2r)-2-amino-3-(3-hydroxypropylsulfanyl)propanoic Acid
21. Fudosteine;
22. Alanine, 3-((3-hydroxypropyl)thio)-, L-
23. Fudosteine [jan]
24. Fudosteine (jp17/inn)
25. Fudosteine [mart.]
26. Fudosteine [who-dd]
27. Schembl230223
28. Chembl1555183
29. Dtxsid4046440
30. Chebi:31637
31. Ss-320a
32. Ss320 A
33. Fudosteine (r)-2-amino-3-(3-hydroxypropylthio)propionic Acid
34. Fudosteine (h-l-cys(proh)-oh)
35. Act10793
36. Hy-b0393
37. Zinc1618869
38. Tox21_112185
39. Mfcd00899873
40. S2129
41. Ss-320
42. Akos010386681
43. Tox21_112185_1
44. Ccg-266419
45. Ds-2359
46. Ncgc00164556-02
47. Ac-19984
48. 2-amino-3-(3-hydroxypropylthio)propionic Acid
49. D01845
50. Ab01274745-01
51. Ab01274745_02
52. 189f985
53. (r)-2-amino-3-(3-hydroxypropylthio)propanoic Acid
54. Q27291223
| Molecular Weight | 179.24 g/mol |
|---|---|
| Molecular Formula | C6H13NO3S |
| XLogP3 | -3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 6 |
| Exact Mass | 179.06161445 g/mol |
| Monoisotopic Mass | 179.06161445 g/mol |
| Topological Polar Surface Area | 109 Ų |
| Heavy Atom Count | 11 |
| Formal Charge | 0 |
| Complexity | 120 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Fudosteine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fudosteine, including repackagers and relabelers. The FDA regulates Fudosteine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fudosteine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Fudosteine supplier is an individual or a company that provides Fudosteine active pharmaceutical ingredient (API) or Fudosteine finished formulations upon request. The Fudosteine suppliers may include Fudosteine API manufacturers, exporters, distributors and traders.
click here to find a list of Fudosteine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Fudosteine Drug Master File in Japan (Fudosteine JDMF) empowers Fudosteine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Fudosteine JDMF during the approval evaluation for pharmaceutical products. At the time of Fudosteine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Fudosteine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fudosteine Drug Master File in Korea (Fudosteine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fudosteine. The MFDS reviews the Fudosteine KDMF as part of the drug registration process and uses the information provided in the Fudosteine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fudosteine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fudosteine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fudosteine suppliers with KDMF on PharmaCompass.
Fudosteine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fudosteine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fudosteine GMP manufacturer or Fudosteine GMP API supplier for your needs.
A Fudosteine CoA (Certificate of Analysis) is a formal document that attests to Fudosteine's compliance with Fudosteine specifications and serves as a tool for batch-level quality control.
Fudosteine CoA mostly includes findings from lab analyses of a specific batch. For each Fudosteine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fudosteine may be tested according to a variety of international standards, such as European Pharmacopoeia (Fudosteine EP), Fudosteine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fudosteine USP).
LOOKING FOR A SUPPLIER?
